Kevin M Knigge

Title: Kevin M Knigge: Innovator in Solid-Phase Binding Assays

Introduction

Kevin M Knigge is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of solid-phase binding assays, with a focus on enhancing the sensitivity and specificity of diagnostic tests. With a total of 3 patents to his name, Knigge's work has had a profound impact on the medical diagnostics industry.

Latest Patents

One of Knigge's latest patents involves the covalent attachment of specific binding members to a solid phase. This innovative method allows for the immobilization of specific binding members, such as antigens or antibodies, to a solid phase like latex microparticles. The process utilizes a coupling agent to form a complex that is then reacted with a dithiol compound, resulting in a thiolated solid phase. This advancement improves the performance of diagnostic binding assays by increasing sensitivity, specificity, and stability while reducing the amount of specific binding member required.

Another significant patent is for a solid phase analytical device and method. This device is designed for solid-phase binding assays to determine the presence or amount of analytes in test samples, particularly antigens or antibodies. The innovative material comprises a porous matrix of fibers and a plurality of solid particles, which are immobilized upon the fibers. This design enhances the efficiency of diagnostic tests, making them more reliable and effective.

Career Highlights

Kevin M Knigge is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to further develop his innovative ideas and contribute to advancements in medical diagnostics.

Collaborations

Throughout his career, Knigge has collaborated with esteemed colleagues, including Emerson W Chan and Werner Schulze. These collaborations have fostered a creative environment that has led to the development of groundbreaking technologies in the field.

Conclusion

Kevin M Knigge's contributions to solid-phase binding assays and diagnostic technologies have established him as a prominent figure in the field. His innovative patents and work at Abbott Laboratories Corporation continue to influence the future of medical diagnostics.